Introduction
eversyn GmbH is an innovative biotechnology startup based in Magdeburg, Saxony-Anhalt, Germany. Founded in 2022, the company is a spin-off from the Max Planck Institute for Dynamics of Complex Technical Systems. eversyn specializes in developing biosynthesis technology to produce nucleotide sugars and high-value oligosaccharides, with applications in nutrition and pharmaceuticals. The company was established by a team of former Max Planck scientists and business professionals, combining deep scientific expertise with entrepreneurial acumen.
eversyn's proprietary technology utilizes enzymatic cascades to produce high-value glycans more efficiently and cost-effectively. This innovative approach positions the company at the forefront of advancements in glycotechnology, particularly in the fields of human milk oligosaccharides and glycosylation of therapeutic proteins.